Evaluation of a Decision-Support Tool for Blood Biomarker Testing for Alzheimer's Disease in Primary Care | MicrobiomeTrials← Back to trialsNCT07812337
Evaluation of a Decision-Support Tool for Blood Biomarker Testing for Alzheimer's Disease in Primary Care
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-10-01Est. Completion: 2027-11-15
Enrollment target: 70 participants Locations- School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, United States
Other microbiome trials you might be interested in
Low Grade AstrocytomaLow Grade GliomaMetastatic Low Grade AstrocytomaMetastatic Low Grade GliomaWHO Grade 1 GliomaWHO Grade 2 Glioma
This phase III trial compares the effect of selumetinib versus the standard of care treatment with carboplatin and vincr…
Birmingham, United StatesEst. completion Dec 31, 2030
Epithelial Ovarian CancerFallopian Tube Cancer
Primary Peritoneal Cancer
The purpose of this study is to evaluate the safety and efficacy of BG-C9074 with bevacizumab (Arm A) versus bevacizumab…
Multiple LocationsEst. completion Nov 30, 2029